180 Life Sciences Corp.

0.9153+0.0454+5.22%Vol 172.82K1Y Perf -91.87%
Jun 24th, 2022 16:00 DELAYED
BID0.8807 ASK0.9200
Open0.9200 Previous Close0.8699
Pre-Market- After-Market0.92
 - -  0.00 0.51%
Target Price
5.00 
Analyst Rating
Hold 3.00
Potential %
446.27 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
1.14 
Earnings Rating
Market Cap22.33M 
Earnings Date
15th Aug 2022
Alpha-0.01 Standard Deviation0.17
Beta-0.12 

Today's Price Range

0.88000.9300

52W Range

0.790011.74

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
9.29%
1 Month
-26.78%
3 Months
-66.35%
6 Months
-78.05%
1 Year
-91.87%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ATNF0.91530.04545.22
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date15th Aug 2022
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume172.82K
Shares Outstanding24.40K
Shares Float29.97M
Trades Count519
Dollar Volume156.12K
Avg. Volume387.96K
Avg. Weekly Volume253.68K
Avg. Monthly Volume439.26K
Avg. Quarterly Volume470.94K

180 Life Sciences Corp. (NASDAQ: ATNF) stock closed at 0.9153 per share at the end of the most recent trading day (a 5.22% change compared to the prior day closing price) with a volume of 172.82K shares and market capitalization of 22.33M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 0 people. 180 Life Sciences Corp. CEO is James N. Woody.

The one-year performance of 180 Life Sciences Corp. stock is -91.87%, while year-to-date (YTD) performance is -76.53%. ATNF stock has a five-year performance of %. Its 52-week range is between 0.79 and 11.7399, which gives ATNF stock a 52-week price range ratio of 1.14%

180 Life Sciences Corp. currently has a PE ratio of -2.00, a price-to-book (PB) ratio of 0.70, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -4.28%, a ROC of -7.47% and a ROE of -8.06%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from 180 Life Sciences Corp., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. 180 Life Sciences Corp.’s next earnings report date is 15th Aug 2022.

The consensus rating of Wall Street analysts for 180 Life Sciences Corp. is Hold (3), with a target price of $5, which is +446.27% compared to the current price. The earnings rating for 180 Life Sciences Corp. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

180 Life Sciences Corp. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

180 Life Sciences Corp. has a Sell technical analysis rating based on Technical Indicators (ADX : 21.10, ATR14 : 0.19, CCI20 : -84.21, Chaikin Money Flow : 0.05, MACD : -0.20, Money Flow Index : 27.35, ROC : -49.98, RSI : 37.19, STOCH (14,3) : 11.29, STOCH RSI : 1.00, UO : 30.57, Williams %R : -88.71), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of 180 Life Sciences Corp. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
3.00
Hold
3.00
Strong Buy
1.00

180 Life Sciences Corp.

180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.

CEO: James N. Woody

Telephone: +1 302 502-2727

Address: 830 Menlo Avenue, Menlo Park 94025, CA, US

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

65%35%

Bearish Bullish

60%40%

Bearish Bullish

62%38%

News

Stocktwits